Percutaneous Closure of Iatrogenic VSD and Paravalvular Leak: Two Complications of TAVR.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
07 2021
Historique:
received: 08 02 2021
accepted: 19 03 2021
pubmed: 29 3 2021
medline: 25 2 2023
entrez: 28 3 2021
Statut: ppublish

Résumé

TAVR is increasingly becoming a common treatment for severe symptomatic aortic stenosis. Although there has been marked reduction in intra-procedural complications with evolution in the TAVR technology, these complications remain a challenge. We present a unique case of paravalvular leak (PVL) and iatrogenic ventricular septal defect as a result of closing attempts of PVL. We aim to highlight our procedural approach to percutaneously repair the aforementioned complications using our heart team approach for decision making.

Identifiants

pubmed: 33773926
pii: S1553-8389(21)00149-4
doi: 10.1016/j.carrev.2021.03.015
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-77

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Shazib Sagheer (S)

University of New Mexico Health Sciences Center, United States of America. Electronic address: ssagheer@salud.unm.edu.

Shane Prejean (S)

University of Alabama at Birmingham Hospital, AL, United States of America.

Thomas Watts (T)

University of Alabama at Birmingham Hospital, AL, United States of America.

Mark A Law (MA)

Division of Interventional Cardiology, University of Alabama at Birmingham Hospital, AL, United States of America.

Mustafa Iltimas Ahmed (MI)

Division of Pediatric Interventional Cardiology, University of Alabama at Birmingham Hospital, AL, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH